Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

about

Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications.Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients.

P2860

Q52650313-A6A34DC6-5D5B-4B6D-9EAF-6C773D92A9A0 Q53702846-1CA094E8-5DE1-42FA-99AF-A59B47B65B4C

P2860

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

Item

http://www.wikidata.org/entity/Q41628351

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reduced Antiplatelet Effect of ...... table Coronary Artery Disease.

@en

type

Item

label

Reduced Antiplatelet Effect of ...... table Coronary Artery Disease.

@en

prefLabel

Reduced Antiplatelet Effect of ...... table Coronary Artery Disease.

@en

P1476

Reduced Antiplatelet Effect of ...... table Coronary Artery Disease.

@en

P2093

Anne-Mette Hvas

http://www.w3.org/2001/XMLSchema#string

Erik Lerkevang Grove

http://www.w3.org/2001/XMLSchema#string

Morten Würtz

http://www.w3.org/2001/XMLSchema#string

Sanne Bøjet Larsen

http://www.w3.org/2001/XMLSchema#string

Søs Neergaard-Petersen

http://www.w3.org/2001/XMLSchema#string

P2860

Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

The prognostic utility of tests of platelet function for the detection of 'aspirin resistance' in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Drug insight: aspirin resistance--fact or fashion?

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis

Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data.

P31

scholarly article

P356

10.1161/JAHA.117.006050

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steen Dalby Kristensen

P577

2017-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28780510

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

P932

5586446

http://www.w3.org/2001/XMLSchema#string

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

about

P2860

P2860

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932